Search results for "testi"

showing 10 items of 4607 documents

Pefloxacin in the Antibacterial Treatment of Immunodepressed Patients

1990

Pefloxacin 800 to 1200 mg daily was given for 3 to 20 days, orally or intravenously, to 84 immunocompromised patients. Five patients dropped out because of side effects and 2 for other causes. Treatment efficacy was evaluated in 77 patients, 43 men and 34 women, aged 18 to 80 years. Immunodepression resulted from malignancy in 46 patients, LAS/ARC or AIDS in 28, and from unknown causes in 3. Fifty-eight patients had documented infections (respiratory-tract infections 29, urinary-tract infections 13, septicemia 10, other 6) and 19 had a fever of unknown origin (FUO). Cure or significant improvement of symptoms was achieved in 81% of patients with documented infections and in 74% of patients …

Adult0301 basic medicinemedicine.medical_specialty030106 microbiologyAIDS-related complexMalignancyPefloxacin03 medical and health sciencesGastrointestinal disturbances0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)NeoplasmsInternal medicineImmune ToleranceHumansMulticenter Studies as TopicMedicinePharmacology (medical)Fever of unknown originAgedAged 80 and overPharmacologyAcquired Immunodeficiency Syndromebusiness.industryBacterial InfectionsMiddle Agedmedicine.diseaseRashPefloxacinTreatment efficacyInfectious DiseasesOncology030220 oncology & carcinogenesismedicine.symptombusinessmedicine.drugJournal of Chemotherapy
researchProduct

The clinical utility of PGD with HLA matching: a collaborative multi-centre ESHRE study

2018

Study question Has PGD-HLA been successful relative to diagnostic and clinical efficacy? Summary answer The diagnostic efficacy of PGD-HLA protocols was found lower in this study in comparison to published PGD-HLA protocols and to that reported for general PGD by ESHRE (78.5 vs 94.1% and vs 92.6%, respectively), while the clinical efficacy has proven very difficult to assess due to inadequate follow-up of both the ART/PGD and HSCT procedure outcomes. What is known already The first clinical cases for PGD-HLA were reported in 2001. It is now a well-established procedure, with an increasing number of cycles performed every year. However, PGD-HLA is still offered by relatively few PGD centres,…

Adult0301 basic medicinemedicine.medical_specialtyPediatricsMEDLINEOocyte RetrievalFertilization in Vitro03 medical and health sciences0302 clinical medicinePregnancymedicineHumansGenetic TestingPreimplantation DiagnosisRetrospective StudiesGenetic testing030219 obstetrics & reproductive medicinemedicine.diagnostic_testbusiness.industryHistocompatibility TestingRehabilitationHematopoietic Stem Cell TransplantationPregnancy OutcomeObstetrics and GynecologyRetrospective cohort studyTissue DonorsTransplantationPregnancy rate030104 developmental biologyReproductive MedicineFemaleOutcomes researchbusinessLive birthCohort studyHuman Reproduction
researchProduct

Different types of intestinal atresia in identical twins

2008

The authors present a previously unreported association of different types of intestinal atresia in identical low-birth-weight twins. Both babies were affected by duodenal atresia, associated in the first case with a complete mucosal duodenal membrane and in the second one with an "apple-peel" jejunal atresia. These occurrences may suggest that they were either the consequence of linkage of 2 genes or a pleiotropic expression of a single gene responsible for such rare conditions.

AdultAbortion Habitualcongenital hereditary and neonatal diseases and abnormalitiesIntestinal AtresiaPhysiologySingle geneInfant Premature DiseasesAnastomosisModels BiologicalDuodenal atresiaDuodenal atresia intestinal atresiamonozygotic twins newbornnewbornPregnancyDiseases in TwinsmedicineHumansInfant Very Low Birth Weightintestinal malformationGeneLaparotomybusiness.industrySettore MED/20 - Chirurgia Pediatrica E InfantileAnastomosis SurgicalIntestinal atresiaInfant NewborntwinsJejunal DiseasesTwins MonozygoticGeneral Medicinemedicine.diseaseJejunumJejunal atresiaPediatrics Perinatology and Child HealthFemaleParenteral Nutrition TotalSurgeryDuodenal ObstructionIdentical twinsbusinessInfant PrematureIntestinal VolvulusJournal of Pediatric Surgery
researchProduct

FOCAL ACTIVE COLITIS AS A PREDICTOR OF INFLAMMATORY BOWEL DISEASE: RESULTS FROM A SINGLE-CENTER EXPERIENCE.

2017

The term focal active colitis (FAC) is conventionally used to describe the presence of isolated cryptitis, characterized by an inflammatory infiltrate consisting of intraepithelial neutrophils and/or neutrophils invading the lumen of the criptae, with no other microscopic alteration of the colonic mucosa and, in particular, without the presence of signs of chronic inflammation. To date, only four studies, including one conducted in a pediatric population, have been performed to evaluate the clinical significance of this disease. The aim of this retrospective study on prospectively-collected data is to evaluate the clinical implications of the focal active colitis, since there still remains …

AdultAged 80 and overMaleAcademic Medical CentersIncidental FindingsSettore MED/12 - GastroenterologiaColonSettore BIO/16 - Anatomia UmanaColonoscopyMiddle AgedColitisInflammatory Bowel DiseasesPrognosisDiagnosis DifferentialItalyDisease ProgressionHumansFemalefocal colitis inflammatory bowel diseases colon microbiota dysbiosisProspective StudiesIntestinal MucosaAgedRetrospective Studies
researchProduct

Havep53 gene mutations and protein expression a different biological significance in colorectal cancer?

2002

p53 alterations are considered the most common genetic events in many types of neoplasms, including colorectal carcinoma (CRC). These alterations include mutations of the gene and/or overexpression of the protein. The aim of our study was to assess whether in 160 patients undergoing resective surgery for primary operable CRC there was an association between p53 mutations and protein over-expression and between these and other biological variables, such as cell DNA content (DNA-ploidy) and S-phase fraction (SPF), and the traditional clinicopathological variables. p53 mutations, identified by PCR-SSCP-sequencing analysis, were found in 68/160 patients (43%) and positive staining for p53 prote…

AdultAged 80 and overMaleBase SequenceDNA Mutational AnalysisP53 colorectal cancerDNAMiddle AgedGenes p53ImmunohistochemistryProtein Structure TertiaryGene Expression Regulation NeoplasticMutationHumansFemaleGenetic TestingProspective StudiesIntestinal MucosaTumor Suppressor Protein p53Colorectal NeoplasmsAged
researchProduct

Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding

2011

*Division of Gastroenterology, and Division of Clinical Epidemiology, McGill University and the McGill University Health Centre, Montreal, Quebec, Canada; INSERM IC-P 803, CHU du Bocage, Dijon, France; Universite de Bourgogne, Dijon, France; **Department of Medicine, Division of Gastroenterology, Farncombe Family igestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada; Guelph General Hospital, Guelph and McMaster University, Guelph, Ontario, Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Division of Gastroenterology, Medical University Canada; f South Carlolina, Charleston, South Carolina; and the Departmen…

AdultAged 80 and overMaleSouth carolinamedicine.medical_specialtyHepatologybusiness.industryGastroenterologyClinical epidemiologyMiddle Agedmedicine.diseaseHealth centreSurgeryFamily medicinemedicineHumansFemaleUpper gastrointestinal bleedingGeneral hospitalGastrointestinal HemorrhagebusinessAgedClinical Gastroenterology and Hepatology
researchProduct

Effect of epidural anesthesia on colorectal anastomosis: a tonometric assessment.

1997

PURPOSE: Epidural anesthesia is believed to benefit colorectal anastomotic blood flow because of the sympathetic blockade it produces. Our purpose is to measure with tonometry the effect of epidural anesthesia on colorectal anastomotic oxygenation. PATIENTS AND METHODS: Fifteen patients operated on for rectal cancer (radical anterior resection) were monitored postoperatively using tonometers placed in the stomach (celiac trunk), transverse colon (superior mesenteric artery), and the anastomotic area during the operation. An epidural catheter was placed at L1-2, and on the first postoperative day, 8 ml of bupivacaine (0.25 percent) was administered. The anesthetic effect extended up to T-4. …

AdultAnesthesia EpiduralMalemedicine.medical_specialtyColonRectumAnastomosisIntestinal mucosamedicine.arterymedicineHumansSuperior mesenteric arteryIntestinal MucosaAgedBupivacainePain Postoperativebusiness.industryStomachAnastomosis SurgicalGastroenterologyTransverse colonRectumGeneral MedicineHydrogen-Ion ConcentrationMiddle AgedBupivacaineColorectal surgerySurgeryOxygenmedicine.anatomical_structureGastric MucosaRegional Blood FlowAnesthesiaFemalebusinessColorectal Neoplasmsmedicine.drugDiseases of the colon and rectum
researchProduct

On-Capillary Surface-Enhanced Raman Spectroscopy: Determination of Glutathione in Whole Blood Microsamples.

2018

Oxidative stress monitoring in the neonatal period supports early outcome prediction and treatment. Glutathione (GSH) is the most abundant antioxidant in most cells and tissues, including whole blood, and its usefulness as a biomarker has been known for decades. To date, the available methods for GSH determination require laborious sample processing and the use of sophisticated laboratory equipment. To the best of our knowledge, no tools suitable for point-of-care (POC) sensing have been reported. Surface-enhanced Raman spectroscopy (SERS), performed in a microvolume capillary measurement cell, is proposed in this study as a robust approach for the quantification of GSH in human whole blood…

AdultAntioxidantSilverSurface Propertiesmedicine.medical_treatmentSample processing02 engineering and technologySpectrum Analysis Raman01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundsymbols.namesakeLimit of DetectionmedicineHumansWhole bloodDetection limitChromatography010401 analytical chemistryInfant NewbornGlutathione021001 nanoscience & nanotechnologyGlutathioneOrders of magnitude (mass)0104 chemical scienceschemistryPoint-of-Care TestingSample SizesymbolsCapillary surface0210 nano-technologyRaman spectroscopyAnalytical chemistry
researchProduct

Mutational analysis of 105 mucopolysaccharidosis type VI patients

2007

Mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy syndrome) is a lysosomal storage disorder caused by mutations in the N-acetylgalactosamine-4-sulfatase (arylsulfatase B, ARSB) gene. ARSB is a lysosomal enzyme involved in the degradation of the glycosaminoglycans (GAG) dermatan and chondroitin sulfate. ARSB mutations reduce enzyme function and GAG degradation, causing lysosomal storage and urinary excretion of these partially degraded substrates. Disease onset and rate of progression is variable, producing a spectrum of clinical presentation. In this study, 105 MPS VI patients—representing about 10% of the world MPS VI population—were studied for molecular genetic and biochemical parame…

AdultArylsulfatase BAdolescentN-Acetylgalactosamine-4-SulfataseMPS VIDNA Mutational AnalysisNonsense mutationMucopolysaccharidosis type VIBiologyPolymorphism Single NucleotideGenetic HeterogeneityAge DistributionGene FrequencyGenotypeGeneticsmedicineHumansMissense mutationGenetic TestingChildCells CulturedGenetics (clinical)mucopolysaccharidosis type VIGlycosaminoglycansGeneticsMucopolysaccharidosis VIGenetic heterogeneityMucopolysaccharidosis VIMiddle Agedmedicine.diseasearylsulfatase BMaroteaux–Lamy syndromeDisease ProgressionARSBMaroteaux-LamyHuman Mutation
researchProduct

Ranking the impact of human health disorders on gut metabolism: Systemic lupus erythematosus and obesity as study cases

2015

Multiple factors have been shown to alter intestinal microbial diversity. It remains to be seen, however, how multiple collective pressures impact the activity in the gut environment and which, if any, is positioned as a dominant driving factor determining the final metabolic outcomes. Here, we describe the results of a metabolome-wide scan of gut microbiota in 18 subjects with systemic lupus erythematosus (SLE) and 17 healthy control subjects and demonstrate a statistically significant difference (p < 0.05) between the two groups. Healthy controls could be categorized (p < 0.05) based on their body mass index (BMI), whereas individuals with SLE could not. We discuss the prevalence of SLE c…

AdultAutoimmunityGut floramedicine.disease_causeArticleAutoimmunityBody Mass IndexmedicineHomeostasisHumansLupus Erythematosus SystemicMetabolomicsClinical significanceMicrobiomeObesityMultidisciplinaryLupus erythematosusbiologyMicrobiotaCase-control studyMiddle Agedmedicine.diseasebiology.organism_classificationObesityN-Acetylneuraminic AcidGastrointestinal TractCase-Control StudiesImmunologyMetabolomeFemaleMicrobiomeBody mass indexMetabolic Networks and PathwaysScientific Reports
researchProduct